Tracking how single cells move in living organisms
New tools for tracking single cells in vivo
This study is testing a new way to follow the movement of individual cells in living organisms, which could help us learn more about how cells work in health and diseases, especially for new treatments like stem cell therapy and immunotherapy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-10734756 on NIH RePORTER |
What this research studies
This research focuses on developing a new method to track the movement of individual cells within living organisms. By creating a system called CellGPS, the researchers aim to monitor the precise location and migration patterns of single cells over time. This approach could provide valuable insights into how cells behave in various biological processes and diseases, particularly in the context of innovative treatments like stem cell therapy and immunotherapy. The methodology involves advanced imaging techniques that allow for real-time tracking of cells, which could enhance our understanding of their roles in health and disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions such as heart failure or diabetes who may benefit from advanced cell therapies.
Not a fit: Patients who do not have conditions related to cell migration or are not candidates for cell-based therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved therapies for conditions like heart failure and diabetes by enabling better tracking of therapeutic cells in the body.
How similar studies have performed: Other research has shown promise in tracking cell movement using advanced imaging techniques, but this specific approach with CellGPS is novel.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Pratx, Guillem — Stanford University
- Study coordinator: Pratx, Guillem
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.